Open AccessFormulary system of drug supply and its formation in the republic of tatarstan
Author(s) -
L. E. Ziganshina,
N. I. Galiullin,
Р. С. Сафиуллин,
N. T. Gazizova,
А. У. Зиганшин
Publication year - 2022
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj96249
Subject(s) - formulary , drug , population , medicine , intensive care medicine , business , product (mathematics) , risk analysis (engineering) , pharmacology , environmental health , geometry , mathematics
Currently, according to WHO, at least 70% of drugs on the world market are duplicates or are not vital drugs. A number of drugs have an unfavorable balance of risk and effect. According to indications, many new drugs do not meet the basic needs of the majority of the population; they are much more expensive than existing drugs. A stable trend in recent years on a global scale is an increase in the cost of drugs, according to WHO experts, by an average of 20% per year, and those that are most often used by the majority of the population (antiulcer, antihypertensive drugs and antibiotics) [1]. In such conditions, the problem of rational use of drugs becomes extremely urgent. In daily practice, doctors need to make the choice of a drug for a particular patient, thereby ensuring the maximum therapeutic effect at a reasonable cost. This choice of medicinal product must be scientifically based.